Skip to main content
Figure 4 | Arthritis Research & Therapy

Figure 4

From: Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren’s syndrome and rheumatoid arthritis

Figure 4

Faecal calprotectin in different patient groups. Individual and median levels of faecal calprotectin in patients with systemic sclerosis (SSc) n = 93, primary Sjögren’s syndrome (pSS) n = 44, rheumatoid arthritis (RA) n = 24 and healthy controls n = 21. Please note the logarithmic scale on the y-axis.

Back to article page